Beta Bionics (BBNX) Total Current Liabilities (2023 - 2026)

Beta Bionics' Total Current Liabilities history runs 4 years deep, the most recent figure standing at $23.2 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 40.62% year-over-year to $23.2 million; the TTM figure through Mar 2026 stood at $23.2 million (up 40.62% YoY), while the FY2025 annual figure was $30.9 million, up 46.23% from the prior year.
• Total Current Liabilities came in at $23.2 million for Q1 2026 at Beta Bionics, down from $30.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $30.9 million in Q4 2025 to a low of $10.6 million in Q4 2023.
• A 4-year average of $21.0 million and a median of $21.1 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities jumped 99.42% in 2024 and jumped 40.62% in 2026, its largest moves.
• Beta Bionics' Total Current Liabilities stood at $10.6 million in 2023, then surged by 99.42% to $21.1 million in 2024, then jumped by 46.23% to $30.9 million in 2025, then dropped by 25.01% to $23.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $23.2 million, $30.9 million, and $25.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison